A new round of price adjustment of traditional Chinese medicine or landing within the year

According to the news, the new round of price adjustment of traditional Chinese medicine will be "implemented" within the year The specific principle of the adjustment is that "there will be a rise, a fall, and a guarantee" The following adjustments are the main ones The industry forecasts a possible range of price adjustments of 10% to 20% Some people in the industry think that the profit of traditional Chinese medicine is still considerable, and the enterprises can still accept the price reduction within a certain range However, for many enterprises, profit narrowing is unavoidable On the other hand, behind the price adjustment of Chinese patent medicine is the promotion of drug price reform of national development and Reform Commission According to the news, the national development and Reform Commission will launch a list of low-cost drugs, with the daily average cost of low-cost drugs controlled at 3 yuan for western medicine and 5 yuan for Chinese patent medicine This is only the first step of drug price reform The latest news that the price adjustment of traditional Chinese medicine will be implemented in this year shows that the window of price adjustment of traditional Chinese medicine, which has attracted much market attention, is about to open, and the price adjustment rules are expected to be implemented in this year According to reports, the national development and Reform Commission's price department disclosed that in the latest price adjustment of traditional Chinese medicine, the national development and Reform Commission has studied a method different from that of chemical drugs, that is, there are ups and downs, and there is a guarantee Among them, most of the prices of traditional Chinese medicine will be lowered Some insiders of the national development and Reform Commission's Macroeconomic Research Institute also confirmed to another media that "the price adjustment plan of Chinese patent medicine may come out in the near future" According to it, at the beginning of this year, the direction of price adjustment of Chinese patent medicine was made clear At the end of last year, the national development and Reform Commission, together with relevant departments, carried out a systematic investigation and Research on the traditional Chinese medicine industry, "from the cultivation, production and processing to sales of traditional Chinese medicine", and completed the work in late July, "relevant plans have been submitted to the phase two months ago Relevant departments " At the same time, the above-mentioned people stressed that the price reduction plan of traditional Chinese medicine has been fully demonstrated, and many different forms of symposiums and expert review meetings have been held and opinions of relevant parties have been widely heard, "this plan, to the maximum extent, protects the interests of all parties." If this news is true, it will be the latest price adjustment faced by Chinese patent medicine in the past four years Since 1997, the national development and Reform Commission has launched 31 drug price adjustments Among them, the latest price reduction of chemicals involved 20 categories of drugs, more than 400 varieties and more than 700 representative dosage forms, with an average price reduction of 15%; while the latest price reduction of Chinese patent medicines was in 2009, when the overall price of more than 1000 basic drugs was reduced by 12% 10% to 20% price reduction since most of the Zhongcheng drugs are faced with price reduction, how much price reduction becomes the focus of attention Experts close to the national development and Reform Commission said that the price reduction of traditional Chinese medicine within the year was almost a foregone conclusion, but the reduction should be small, with the possible adjustment range of 10% to 20% In fact, in recent years, the price of cheap and convenient traditional Chinese medicine has been rising Since April this year, the market price of traditional Chinese medicine in China has been rising, and the export price has also been rising sharply In the first three quarters of 2013, the export volume of Chinese herbal medicines was 148675 tons, an increase of 4.32% year-on-year, while the average export price increased by 38.18% year-on-year According to the news, the new round of price adjustment of traditional Chinese medicine will be "implemented" within the year The specific principle of the adjustment is that "there will be a rise, a fall, and a guarantee" The following adjustments are the main ones The industry forecasts a possible range of price adjustments of 10% to 20% Some people in the industry think that the profit of traditional Chinese medicine is still considerable, and the enterprises can still accept the price reduction within a certain range However, for many enterprises, profit narrowing is unavoidable On the other hand, behind the price adjustment of Chinese patent medicine is the promotion of drug price reform of national development and Reform Commission According to the news, the national development and Reform Commission will launch a list of low-cost drugs, with the daily average cost of low-cost drugs controlled at 3 yuan for western medicine and 5 yuan for Chinese patent medicine This is only the first step of drug price reform The latest news that the price adjustment of traditional Chinese medicine will be implemented in this year shows that the window of price adjustment of traditional Chinese medicine will be opened soon, and the price adjustment rules are expected to be implemented in this year According to reports, the price department of the national development and Reform Commission disclosed that in the latest price adjustment of traditional Chinese medicine, the development and Reform Commission has studied a method different from that of chemical drugs, that is to say, there is a guarantee of rising and falling Among them, most of the prices of traditional Chinese medicine will be lowered Some insiders of the national development and Reform Commission's Macroeconomic Research Institute also confirmed to another media that "the price adjustment plan of Chinese patent medicine may come out in the near future" According to it, at the beginning of this year, the direction of price adjustment of Chinese patent medicine was made clear At the end of last year, the national development and Reform Commission, together with relevant departments, carried out a systematic investigation and Research on the traditional Chinese medicine industry, "from the cultivation, production and processing to sales of traditional Chinese medicine", and completed the work in late July, "relevant plans have been submitted to the phase two months ago Relevant departments " At the same time, the above people stressed that the price reduction plan of traditional Chinese medicine has been fully demonstrated, and held many different forms of symposiums, expert review meetings and widely listened to the opinions of the relevant parties, "this plan, to the maximum extent, protects the interests of all parties." If this news is true, it will be the latest price adjustment faced by Chinese patent medicine in the past four years Since 1997, the national development and Reform Commission has launched 31 drug price adjustments Among them, the latest price reduction of chemicals involved 20 categories of drugs, more than 400 varieties and more than 700 representative dosage forms, with an average price reduction of 15%; while the latest price reduction of Chinese patent medicines was in 2009, when the overall price of more than 1000 basic drugs was reduced by 12% 10% to 20% price reduction since most of the Zhongcheng drugs are faced with price reduction, how much price reduction becomes the focus of attention Experts close to the national development and Reform Commission said that the price reduction of traditional Chinese medicine within the year was almost a foregone conclusion, but the reduction should be small, with the possible adjustment range of 10% to 20% In fact, in recent years, the price of cheap and convenient traditional Chinese medicine has been rising Since April this year, the market price of traditional Chinese medicine in China has been rising again, and the export price has also increased significantly In the first three quarters of 2013, the export volume of Chinese herbal medicines was 148675 tons, an increase of 4.32% year-on-year, while the average export price increased by 38.18% year-on-year Just a week before the news of the price adjustment of Chinese patent medicine came out, the comprehensive 200 index of Chinese herbal medicine prices fluctuated slightly As of November 12, the overall index closed at 2594.38, up 0.215% on a weekly basis Expert analysis, due to the rapid rise in the price of traditional Chinese medicine in recent years, the cost of enterprises is higher, this round of price reduction is more just "meaning" On the other hand, relevant persons from the price department of the national development and Reform Commission also disclosed that for some Chinese patent medicines with prices below 5 yuan and some medicines that can no longer be guaranteed to be produced, the prices will remain stable or even increase In addition, experts attending the expert meeting on the price adjustment of traditional Chinese medicine told the media that there are three conditions for the price increase of traditional Chinese medicine: first, to reach the fixed price and be included in the 2010 Pharmacopoeia; Secondly, the cost of Chinese herbal medicine accounts for more than 50% of the manufacturing cost The main herbal medicine is wild or perennial, which has not been cultivated on a large scale, or is greatly affected by the location, climate and other factors, and the price has continued to rise more than six times in the past five years Finally, the price difference between the market price and the maximum retail price limit is not more than 25% According to the analysis of industry insiders, the pressure on small and medium-sized enterprises of traditional Chinese medicine will be greater and the impact on large enterprises will be limited Fang Shuting, President of China Association of traditional Chinese medicine, told the media, "the profit of traditional Chinese medicine is quite considerable For example, the gross profit margin of Tanreqing injection of Shanghai Kaibao is 84.29%; the gross profit margin of Xueshuantong series of Zhongheng group is 85%." If the decline is to a certain extent, enterprises can still accept it Although relevant people believe that the price adjustment of Chinese patent medicine is not large and takes into account the interests of all parties, for most pharmaceutical enterprises, narrowing profits will be inevitable Researchers in CITIC Securities industry believe that "the price reduction of traditional Chinese medicine has a great impact on enterprises" At present, there are many problems in the market of traditional Chinese medicine, such as inferior quality, price fluctuation, information asymmetry, confusion of circulation channels, insufficient reserve of traditional Chinese medicine, and in the bidding process, some competitive varieties have lowered the factory price through bidding, etc "If the price is reduced forcibly, it may lead to the situation that bad money drives out good money, leading to the weak competition of many high-quality products." For specific categories, a relevant person in charge of the China Association of traditional Chinese medicine said that the profit margin of traditional Chinese medicine injection was too high, or it would lead to the "most drastic" price reduction At the same time, pharmaceutical enterprises with a market value of 1.16 trillion will face more severe tests Behind the price adjustment of Chinese patent medicine is the promotion of drug price reform by the national development and Reform Commission According to the news, the national development and Reform Commission will launch a list of low-cost drugs Low price medicine refers to the medicine with relatively low cost in the same kind of medicine for treating a certain disease According to the opinions of the national development and Reform Commission, the daily average cost of low-cost drugs is controlled at 3 yuan for western medicine and 5 yuan for Chinese patent medicine According to media analysis, the list of low-cost drugs is the first step for the national development and Reform Commission to launch drug price reform this year, which will have a huge impact on the entire pharmaceutical industry - low-cost drugs will be protected and returned to the market; the market space of high-cost drugs will be squeezed, and the whole pharmaceutical enterprise is expected to usher in a high tide of M & A.